• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Elife . The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein

tetano

Editor, Senior Moderator
Elife


. 2022 Mar 24;11:e75720.
doi: 10.7554/eLife.75720. Online ahead of print.
The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein


Hisham M Dokainish[SUP] 1 [/SUP], Suyong Re[SUP] 2 [/SUP], Takaharu Mori[SUP] 3 [/SUP], Chigusa Kobayashi[SUP] 4 [/SUP], Jaewoon Jung[SUP] 4 [/SUP], Yuji Sugita[SUP] 1 [/SUP]



Affiliations

Abstract

Spike (S) protein is the primary antigenic target for neutralization and vaccine development for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It decorates the virus surface and undergoes large motions of its receptor binding domains (RBDs) to enter the host cell. Here, we observe Down, one-Up, one-Open, and two-Up-like structures in enhanced molecular dynamics simulations, and characterize the transition pathways via inter-domain interactions. Transient salt-bridges between RBD[SUB]A[/SUB] and RBD[SUB]C[/SUB] and the interaction with glycan at N343[SUB]B[/SUB] support RBD[SUB]A[/SUB] motions from Down to one-Up. Reduced interactions between RBD[SUB]A[/SUB] and RBD[SUB]B[/SUB] in one-Up induce RBD[SUB]B[/SUB] motions toward two-Up. The simulations overall agree with cryo-EM structure distributions and FRET experiments and provide hidden functional structures, namely, intermediates along Down to one-Up transition with druggable cryptic pockets as well as one-Open with a maximum exposed RBD. The inherent flexibility of S-protein thus provides essential information for antiviral drug rational design or vaccine development.

Keywords: biochemistry; chemical biology; human; molecular biophysics; structural biology.
 
Back
Top Bottom